Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × zipalertinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Lung Neoplasms 1 Carcinoma 1

Interventions

pembrolizumab 84 Carboplatin 71 Specimen Handling 67 Pemetrexed 61 Magnetic Resonance Spectroscopy 56 Cisplatin 46 durvalumab 43 Paclitaxel 35 Nivolumab 30 osimertinib 27 atezolizumab 27 Radiosurgery 26 Biopsy 24 Docetaxel 23 Standard of Care 22 Radiotherapy 22 Immunoglobulin G 22 Disulfides 21 Blood Specimen Collection 21 Gemcitabine 19 Radiation 18 Practice Guidelines as Topic 18 Drug Therapy 18 Etoposide 16 Taxes 15 Educational Status 15 X-Rays 13 Bevacizumab 12 130-nm albumin-bound paclitaxel 12 Surveys and Questionnaires 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07128199 2026-02-03

REZILIENT4

Taiho Oncology, Inc.

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡